ILC Therapeutics
Chris has worked with a number of life sciences companies as both a Director and Non-Executive Director. He has broad experience with a strong commercial focus. He has led and executed transactions valued in excess of $800million.
This person is not in the org chart
This person is not in any offices
ILC Therapeutics
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.